CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus

Cancer Research

Volumn 75, Issue 15, 2015, Pages 3155-3166

  Russell, Mike R ^a   Penikis, Annalise ^a   Oldridge, Derek A ^a   Alvarez Dominguez, Juan R ^b,c   McDaniel, Lee ^a   Diamond, Maura ^a   Padovan, Olivia ^d   Raman, Pichai ^a   Li, Yimei ^a   Wei, Jun S ^e   Zhang, Shile ^e   Gnanchandran, Janahan ^f   Seeger, Robert ^f   Asgharzadeh, Shahab ^f   Khan, Javed ^e   Diskin, Sharon J ^a,g,h   Maris, John M ^a,g,h   Cole, Kristina A ^a,g,h  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA;

ADVANCED CANCER; ANIMAL CELL; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CASC15 S GENE; CASE CONTROL STUDY; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CHROMOSOME 6P; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NERVE CELL DIFFERENTIATION; NERVE GROWTH; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; CELL DIFFERENTIATION; CHROMOSOME 6; GENETIC PREDISPOSITION; GENETICS; MORTALITY; PATHOLOGY; REPRODUCIBILITY; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 6; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEUROBLASTOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; RNA, LONG NONCODING;

EID: 84942910235     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3613     Document Type: Article

References (49)

1. Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010;362: 2202-11.
2. Brodeur GM. Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 2003;3: 203-16.
3. Cheung N-K V, Dyer M. Neuroblastoma: Developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 2013;13: 397-411.
4. Takahashi Y, Sipp D, Enomoto H. Tissue interactions in neural crest cell development and disease. Science 2013;341: 860-3.
5. Maris JM, Mosse YP, Bradfield JP, Hou C, Monni S, Scott RH, et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N Engl J Med 2008;358: 2585-93.
6. Capasso M, Devoto M, Hou C, Asgharzadeh S, Glessner JT, Attiyeh EF, et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat Genet 2009;41: 718-23.
7. Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature 2009;459: 987-91.
8. Nguyen le B, Diskin SJ, Capasso M, Wang K, Diamond MA, Glessner J, et al. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility loci. PLoS Genet 2011;7: E1002026.
9. Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 2011; 469: 216-20.
10. Diskin SJ, Capasso M, Schnepp RW, Cole KA, Attiyeh EF, Hou C, et al. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nat Genet 2012;44: 1126-30.
11. Latorre V, Diskin SJ, Diamond MA, Zhang H, Hakonarson H, Maris JM, et al. Replication of neuroblastoma snp association at the BARD1 locus in African-Americans. Cancer Epidemiol Biomarkers Prev 2012;21: 658-63.
12. Capasso M, Diskin SJ, Totaro F, Longo L, De Mariano M, Russo R, et al. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility. Carcinogenesis 2013;34: 605-11.
13. Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 2012;483: 589-93.
14. Sausen M, Leary RJ, Jones S, Wu J, Reynolds CP, Liu X, et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat Genet 2013;45: 12-7.
15. Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, et al. The genetic landscape of high-risk neuroblastoma. Nat Genet 2013;45: 279-84.
16. Cheung N, Zhang J, Lu C, Parker M. Association of age at diagnosis and geneticmutations in patients with neuroblastoma. JAMA 2012;307: 1062-71.
17. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461: 747-53.
18. Bertone P, Stolc V, Royce TE, Rozowsky JS, Urban AE, Zhu X, et al. Global identification of human transcribed sequences with genome tiling arrays. Science 2004;306: 2242-6.
19. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, MaedaN, et al. The transcriptional landscape of the mammalian genome. Science 2005;309: 1559-63.
20. Mercer T, Dinger M, Mattick J. Long non-coding RNA insights into functions. Nat Rev Genet 2009;10: 155-9.
21. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012;81: 145-66.
22. Lee JT. Epigenetic regulation by long noncoding RNAs. Science 2012;338: 1435-9.
23. Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol 2013;20: 300-7.
24. Chu C, Qu K, Zhong F, Artandi S, Chang H. Genomic maps of lincRNA occupancy reveal principles of RNA chromatin interactions. Mol Cell 2011;44: 667-78.
25. Ponjavic J, Oliver PL, Lunter G, Ponting CP. Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS Genet 2009;5: E1000617.
26. Knauss JL, Sun T. Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function. Neuroscience 2013;3: 200-14.
27. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011;10: 38.
28. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011;1: 391-407.
29. Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 2013;45: 1392-8.
30. Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013;73: 1180-9.
31. Federico S, Brennan R, Dyer M. Childhood cancer and developmental biology: A crucial partnership. Top Dev Biol 2011;901: 1-10.
32. http://target.nci.nih.gov/dataMatrix/TARGET-DataMatrix.html
33. Raj A, van den Boogard P, Rifkin SA, van Oudenaarden A, Tyagi S. Imaging individual mRNA molecules using multiple singly labeled probes. Nature Methods 2008;5: 877-79.
34. Delaneau O, Marchini J, Zagury JF. A linear complexity phasingmethod for thousands of genomes. Nat Methods 2011;9: 179-81.
35. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009;5: E1000529.
36. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39: 906-13.
37. Visel A, Minovitsky S, Dubchak I, Pennacchio LA. VISTA Enhancer Browsera database of tissue-specific human enhancers. Nucleic Acids Res 2007;35: D88-92
38. Zhang X, Bailey SD, Lupien M. Laying a solid foundation for Manhattan-'setting the functional basis for the post-GWAS era'. Trends Genet 2014; 30: 140-9.
39. Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H, et al. Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN amplification. J Natl Cancer Inst 2006; 98: 1193-203.
40. Mossé YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 2008;455: 930-5.
41. Mosse YP, Laudenslager M, Khazi D, Carlisle AJ, Winter CL, Rappaport E, et al. Germline PHOX2B mutation in hereditary neuroblastoma. Am J Hum Genet 2004;75: 727-30.
42. Pandey GK, Mitra S, Subhash S, Hertwig F, Kanduri M, Mishra K, et al. The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell 2014;26: 722-37.
43. Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010;143: 46-58.
44. Barnhill LM, Williams RT, Cohen O, Kim Y, Batova A, Mielke JA, et al. High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma. Cancer Res 2014;74: 3753-63.
45. Liu PY, Erriquez D, Marshall GM, Tee AE, Polly P, Wong M, et al. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. J Natl Cancer Inst 2014;106: 1-11.
46. Tee A, Ling D, Nelson C, Atmadibrata B, DingerM, Xu N, et al. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget 2014;5: 1793-804.
47. Atmadibrata B, Liu PY, Sokolowski N, Zhang L, Wong M, Tee AE, et al. The novel long noncoding RNA linc00467 promotes cell survival but is downregulated by N-Myc. PLoS ONE 2014;9: E88112.
48. Suvá ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 2014;157: 580-94.
49. Rheinbay E, Suvá ML, Gillespie SM, Wakimoto H, Patel AP, Shahid M, et al. An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell Rep 2013;3: 1567-79.